THERAPEUTIC PREFERENCES OF ADDICTION SPECIALISTS IN SAINT-PETERSBURG


Cite item

Full Text

Abstract

We have done the analysis of therapeutic preferences of alcohol or drug abuse therapists in the treatment of alcoholism and opioid addiction at the present stage. Through anonymous questionnaires we have received the results from 132 alcohol or drug abuse therapists. The questionnaire consisted of 72 questions that reflected the preferences of addiction specialists in pharmacotherapy and psychotherapy, and also the subjective assessment of patients’ attitude to the different methods of treatment. It was found out that alcohol or drug abuse therapists from psychotherapeutic techniques often use cognitive-behavioral and family counseling. About 80% of alcohol or drug abuse therapists continue to use with different frequency traditional but not scientifically proved methods (“coding” (alcohol or drug abuse hypnosis), simulation of “Anti addiction substance” (placebo) implantation, etc). Alcohol or drug abuse therapists widely use neuroleptics, antidepressants, anticonvulsants, normotimics, tranquilizers and nootropics, and in the treatment of alcoholism; these tools are used more often than in the treatment of drug addiction. Over 80% of alcohol or drug abuse therapists administer Disulfiram and Cyanamide, of which 48,2% are often Disulfiram and 45.5% - Cyanamide. More than 21% of alcohol or drug abuse therapists are given different forms of Naltrexone in the treatment of alcoholism, and in the treatment of drug addiction - more than 25%. Naltrexone for extended-release injectable suspension (Vivitrol) is known by the absolute majority of alcohol or drug abuse therapists, however, nearly half of doctors don’t use it or have minimal experience. Doctors with experience in the use of Vivitrol assess its efficiency as average, noting a weak manifestation of side effects. The main goal of treatment of patients with alcoholism and drug addiction, according to experts, is achievement of remission, although about one third of experts consider that the purpose of drug treatment may be reduction of utilisation of psychoactive substances and relief of abstinence. Doctors consider that unscientific methods of treatment are demanded by 39.2% of patients with alcoholism and 31.2% of patients with opioid addiction and treatment with Naltrexone are demanded by 4.5% and 9.4% of patients.

About the authors

Alexander G Sofronov

1) North-Western I.I. Mechnikov state medical university; 2) St. Petersburg research I.I. Ganelidze Insitute of emergency aid

1) 191015, Saint-Petersburg, Kirochnaya street,41; 2) 192242, St. Petersburg, Budapestskaya street, 3

Alla E Dobrovolskaya

North-Western I.I. Mechnikov state medical university

Email: maxmmm@yandex.ru
191015, Saint-Petersburg, Kirochnaya street,41

Alexei Yu Egorov

1) North-Western I.I. Mechnikov state medical university; 2) I.M. Sechenov Institute of evolutional physiology and biochemistry; 3) St. Petersburg state university

1) 191015, Saint-Petersburg, Kirochnaya street,41; 2) St. Petersburg, 19422, Тоrez Street, 44; 3) 199034, St. Petersburg , University embankment, 7-9

References

  1. Зобин М.Л. Отечественная наркология: 35 лет самостоятельного пути. Неутешительные итоги. http://www.narcom.ru/publ/info/962
  2. Крупицкий Е.М. Краткосрочное интенсивное психотерапевтическое вмешательство в наркологии с позиций доказательной медицины// Неврологический вестник. 2010. Т. 42, №3. С. 25-27.
  3. Крупицкий Е.М. Наукообразно декорируемые подходы к терапии в российской наркологии: размышления по поводу статьи М.Л. Зобина «Плацебо технологии в терапии химических аддикций» // Журнал неврол. психиатр. им С.С. Корсакова. 2014. Т. 114. (5, Вып. 2 «Аддиктивные расстройства»). С. 89-92.
  4. Менделевич В.Д. Наркомания и наркология в России в зеркале общественного мнения и профессионального анализа. Казань: Медицина, 2006.
  5. Менделевич В.Д. Социологический анализ «анозогнозической установки» наркологов по отношению к наркомании: отечественные и зарубежные реалии // Наркология. 2011. № 4. С. 69-74.
  6. Менделевич В.Д. Психопатологизация наркологических расстройств как доминирующая парадигма отечественной наркологии // Независимый психиатрический журнал. 2010. № 3. С. 21-27.
  7. Сиволап Ю.П. Федеральные стандарты по диагностике и лечению в наркологии: критический анализ // Наркология. 2014. № 9. С. 68-74.
  8. Софронов А.Г. Актуальные проблемы развития отечественной наркологии // Наркология. 2003. №3. С. 2-7.
  9. Стандарт первичной медико-санитарной помощи при синдроме зависимости, вызванном употреблением психоактивных веществ. М., 2012. http://oknb74.ru/standart-pervichnoy-mediko-sanitarnoy-pomoshchi-pri-sindrome-zavisimosti-vyzvannom-upotrebleniem
  10. Торбан М.Н., Илюк Р.Д., Крупицкий Е.М., Хаймер Р. Исследование представлений врачей-наркологов РФ о работе наркологической службы. СПб: Изд. СПб НИПНИ им. В.М. Бехтерева, 2010.
  11. Шереги Ф.Э., Арефьев А.Л. Оценка наркоситуации в среде детей, подростков и молодежи. Доклад. М.: Изд-во «Оптим Груп», 2003.
  12. Шкутина И.В., Мироненко Н.В., Шкутина Г.Н., Афиногенов Ю.П. Оценка наркологической ситуации в молодежной среде // Вестник ВГУ. Серия химия, биология, фармация. 2011. № 2. С. 154-158.
  13. Campbell N.D. Discovering Addiction: The Scitnce and Politics of Substance Abuse Research. Ann Arbor, MI: University of Michigan Press, 2007.
  14. Dawson. D.A. Defining risk drinking // Alcohol Research & Health. 2011. Vol. 34, № 2. P. 144-156.
  15. International Center for Alcohol Policy ICAP http://www.icap.org/
  16. Kishi T., Sevy S, Chekuri R., Correll C.U. Antipsychotics for primary alcohol dependence: A systematic review and meta-analysis of placebo-controlled trials // The Journal of Clinical Psychiatry. 2013. Vol. 74, № 7. P. 642-654.
  17. Klingemann H., Rosenberg H. Acceptance and therapeutic practice of controlled drinking as an outcome goal by Swiss alcohol treatment programs // Eur Addict Res. 2009. Vol. 15, N 3. P. 121-127.
  18. Mäkelä P., Martikainen P., Nihtilä E. Temporal variation in deaths related to alcohol intoxication and drinking // Int J Epidemiol. 2005. Vol. 34, N 4. P. 765-271.
  19. Preliminary results from the 1997 national household survey on drug abuse. Rockville, SAMHSA. 1998.
  20. Rehm J., Gmel G., Sempos C.T., Trevisan M., Alcohol-related morbidity and mortality // Alcohol Research & Health. 2003. Vol. 27, N. 1. P. 39-51.
  21. Rehm J., Rehm M.X., Alho H. et al. Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland International Journal of Alcohol and Drug Research // IJADR. 2013. Vol. 2, N 2. P. 53-67.
  22. Volpicelli J.R., Pettinati H.M., McLellan A.T., O’Brien C.P. BRENDA Manual: Compliance Enhancement Techniques with Pharmacotherapy for Alcohol and Drug Dependence. Gilford Press; Philadelphia, PA: 1997.

Copyright (c) 2016 Sofronov A.G., Dobrovolskaya A.E., Egorov A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies